A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
10/2002
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020151796 Echogenic devices and methods of making and using such devices
10/17/2002	US20020151792 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
10/17/2002	US20020151787 Method of tumor imaging
10/17/2002	US20020151465 Decrease hyperalgesia, without impairing nociception
10/17/2002	US20020151014 Modified bioluminescent proteins and their use
10/17/2002	US20020150918 Method for detection of biological factors in epidermis
10/17/2002	US20020150539 Ultrasound imaging and treatment
10/17/2002	US20020150538 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
10/17/2002	US20020150537 Sensitization of an animal with allergen; detecting immunology response
10/17/2002	CA2443362A1 Stabilization and terminal sterilization of phospholipid formulations
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443099A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
10/17/2002	CA2443057A1 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442382A1 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	CN1374855A Improved diagnostic method for detecting dysplastic epithelial tissue
10/16/2002	CN1374133A B-mode ultrasound coupling agent and its prepn
10/15/2002	US6466814 Ex vivo polarization of a high t1 agent, especially one that is carbon 13-enriched at one or more carbonyl or quaternary carbon positions.
10/10/2002	WO2002079778A2 In vivo delivery methods and compositions
10/10/2002	WO2002078863A1 Generation of pharmaceutical agent particles using focused acoustic energy
10/10/2002	WO2002078694A1 Photosensitiser and method for production thereof
10/10/2002	WO2002078688A1 Irrigating fluid
10/10/2002	WO2002078638A2 Morpholino imaging and therapy
10/10/2002	WO2002078611A2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
10/10/2002	WO2002055111A3 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
10/10/2002	WO2001077174A3 Human transporters and ion channels
10/10/2002	WO2001068151A3 Functional radiographic imaging methods and agents
10/10/2002	WO2001053324A8 Novel haptotactic peptides
10/10/2002	US20020147997 Animal model for use in the diagnosis, prevention and treatment of cancer
10/10/2002	US20020147316 Medical diagnosis, therapy
10/10/2002	US20020147223 Agent for enhancing accumulation of drugs in tumor tissues
10/10/2002	US20020147136 Tetrapeptide
10/10/2002	US20020146821 Bone marrow cells as a source of neurons for brain and spinal cord repair
10/10/2002	US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002	US20020146371 Methods for development and use of diagnostic and therapeutic agents
10/10/2002	US20020146369 Intraoperative, intravascular and endoscopic tumor and lesion detection, biopsy and therapy
10/10/2002	CA2442730A1 Irrigating fluid
10/09/2002	EP1246830A1 Macrocyclic chelants for metallopharmaceuticals
10/09/2002	EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002	EP0868434B1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/09/2002	CN1373765A Calcium complex of phosphorus contg. ethylenediamine derivs.
10/09/2002	CN1092182C Process for preparation of contrast agent
10/08/2002	US6463318 Method and apparatus for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
10/08/2002	US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment
10/08/2002	US6462090 Formulations for detecting asthma
10/08/2002	US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity
10/08/2002	US6461824 Production of chimeric antibodies with specificity to human tumor antigens
10/08/2002	US6461589 Standardized compositions which facilitate swallowing in dysphagic subjects
10/08/2002	US6461588 Use of bile acid conjugates, derivatives thereof with metal complexes as blood pool agents for nuclear magnetic resonance diagnostics
10/08/2002	US6461587 Perfluoroalkylamides, their production and their use in diagnosis
10/08/2002	US6461586 Method of magnetic resonance focused surgical and therapeutic ultrasound
10/03/2002	WO2002077237A2 Transporters and ion channels
10/03/2002	WO2002077236A2 Compositions and methods relating to lung specific genes and proteins
10/03/2002	WO2002076510A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002	WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002	WO2002076491A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002	WO2002055027A3 Placebo effect and relaxation response
10/03/2002	WO2002045590A9 Method for regional administeration of preparations for curing liver tumors
10/03/2002	WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002	WO2001085983A3 Methods for testing compounds useful for treating diabetic complications
10/03/2002	WO2001071004A3 Proteases
10/03/2002	WO2001030396A3 Improved suspensions of ultrasound contrast media
10/03/2002	WO2001020331A9 Substrates and screening methods for transport proteins
10/03/2002	US20020144301 Animal model for use in the diagnoois and treatment of prostate cancer
10/03/2002	US20020143063 For for conditioning hair
10/03/2002	US20020143012 For imaging amyloid deposits
10/03/2002	US20020142943 A drug and an agent capable of inducing the dephosphorylation of phosphorylated serine and/or threonine residue of p100 and/or p120, wherein the ability of the drug to cross a physiological barrier is improved.
10/03/2002	US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002	US20020142391 Synthesis of human procollagens and collagens in recombinant DNA systems
10/03/2002	US20020142343 Preparing substrate for detecting preferential particle in sample; obtain sample, expose to elution buffer, detect preferential particle by desorption spectrometry, incubate with substrate, recover preferential particle
10/03/2002	US20020142049 Precipitating drug as solid
10/03/2002	US20020141943 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy
10/03/2002	CA2442080A1 A preparation for restenosis prevention
10/03/2002	CA2441227A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002	CA2439630A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002	CA2438206A1 Transporters and ion channels
10/02/2002	EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002	DE10115740A1 Zubereitung für die Restenoseprophylaxe Preparation for the prophylaxis of restenosis
10/02/2002	DE10112470A1 Verfahren zur Proben-Identifizierung bei einem Säugetier sowie ein Kit zur Durchführung dieses Verfahrens A method for sample identification in a mammal, and a kit for carrying out this method
10/02/2002	CN1372637A Methylene blue diagnostic agent and diagnostic methods for detection of epithelita cancer
10/02/2002	CN1372567A Method for isolating and purifying grass pollen allergens
10/01/2002	US6458937 Glycoconjugates and methods
10/01/2002	US6458764 GRF analogs with increased biological potency
10/01/2002	US6458758 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/01/2002	US6458337 Diagnostic imaging contrast agent with improved in serum relaxivity
10/01/2002	CA2213935C Diagnostic agent for diabetes
10/01/2002	CA2119930C Production of chimeric antibodies - a combinatorial approach
10/01/2002	CA2077670C Method for enhancing antibody transport through capillary barriers
10/01/2002	CA2068632C Nanocrystalline magnetic iron oxide particles, processes for their preparation and their use in medical diagnostics and therapy
09/2002
09/26/2002	WO2002075569A1 Encapsulating fibre channel signals for transmission over non-fibre channel networks
09/26/2002	WO2002075318A2 Neurofibrillary labels
09/26/2002	WO2002075307A1 Method for sample identification in a mammal as well as a kit for performing this method
09/26/2002	WO2002075278A2 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor
09/26/2002	WO2002074346A2 Targeting chemical compounds to cells
09/26/2002	WO2002074339A1 Deveice and method for the photodynamic diagnosis of tumor tissue
09/26/2002	WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
09/26/2002	WO2002074171A1 Fluorescent cobalamins and uses thereof

1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 354